2023 Q2 Form 10-Q Financial Statement

#000155335023000285 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $10.64M $13.08M $9.265M
YoY Change -15.66% 41.17% -21.08%
Cost Of Revenue $7.280M $9.268M $6.407M
YoY Change -20.64% 44.65% -12.83%
Gross Profit $3.360M $3.811M $2.858M
YoY Change -2.38% 33.34% -34.9%
Gross Profit Margin 31.58% 29.14% 30.85%
Selling, General & Admin $1.050M $1.033M $1.165M
YoY Change -30.6% -11.33% -17.96%
% of Gross Profit 31.25% 27.11% 40.76%
Research & Development $700.0K $713.0K $658.0K
YoY Change -3.58% 8.36% -40.18%
% of Gross Profit 20.83% 18.71% 23.02%
Depreciation & Amortization $270.0K $210.0K $180.0K
YoY Change 50.0% 16.67% 0.0%
% of Gross Profit 8.04% 5.51% 6.3%
Operating Expenses $1.750M $1.746M $1.837M
YoY Change -21.84% -4.95% -27.1%
Operating Profit $1.610M $2.065M $1.021M
YoY Change 33.83% 102.25% -45.4%
Interest Expense $3.580M $131.0K -$387.0K
YoY Change 1058.58% -133.85% -153.75%
% of Operating Profit 222.36% 6.34% -37.9%
Other Income/Expense, Net $122.0K -$232.0K
YoY Change -152.59% -125.78%
Pretax Income $5.190M $1.768M $634.0K
YoY Change 248.09% 178.86% -75.52%
Income Tax $1.390M $455.0K $172.0K
% Of Pretax Income 26.78% 25.74% 27.13%
Net Earnings $3.810M $1.313M $462.0K
YoY Change 171.17% 184.2% -76.9%
Net Earnings / Revenue 35.81% 10.04% 4.99%
Basic Earnings Per Share $0.37 $0.13
Diluted Earnings Per Share $1.06 $0.36 $123.2K
COMMON SHARES
Basic Shares Outstanding 3.545M shares 3.544M shares 3.626M shares
Diluted Shares Outstanding 3.623M shares 3.749M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.59M $4.771M $5.890M
YoY Change 622.63% -19.0% 17.8%
Cash & Equivalents $2.936M $2.088M $4.761M
Short-Term Investments $8.655M $2.683M $1.129M
Other Short-Term Assets $790.0K $1.919M $1.663M
YoY Change -47.33% 15.39% 29.92%
Inventory $16.17M $15.15M $11.87M
Prepaid Expenses $296.0K
Receivables $9.952M $10.57M $8.680M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $30.98M $31.15M $28.10M
YoY Change -0.6% 10.84% 5.75%
LONG-TERM ASSETS
Property, Plant & Equipment $5.079M $5.162M $13.34M
YoY Change -62.16% -61.3% 8.81%
Goodwill
YoY Change
Intangibles $81.00K $87.00K
YoY Change -31.36%
Long-Term Investments $7.520M $1.534M $1.778M
YoY Change 322.71% -13.72% -41.32%
Other Assets $42.00K $42.00K $505.0K
YoY Change -94.99% -91.68% 68.33%
Total Long-Term Assets $20.84M $15.83M $15.79M
YoY Change 28.99% 0.29% 0.22%
TOTAL ASSETS
Total Short-Term Assets $30.98M $31.15M $28.10M
Total Long-Term Assets $20.84M $15.83M $15.79M
Total Assets $51.82M $46.98M $43.88M
YoY Change 9.5% 7.04% 3.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.261M $3.068M $3.533M
YoY Change -39.88% -13.16% 40.2%
Accrued Expenses $3.135M $2.425M $1.652M
YoY Change 13.96% 46.79% -37.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.830M $3.114M $1.642M
YoY Change 16.59% 89.65% 47.93%
Total Short-Term Liabilities $9.676M $10.14M $7.723M
YoY Change -10.49% 31.35% 19.18%
LONG-TERM LIABILITIES
Long-Term Debt $8.910M $9.247M $10.58M
YoY Change -13.07% -12.56% -9.62%
Other Long-Term Liabilities $1.640M $1.745M $3.315M
YoY Change -36.87% -47.36% -11.13%
Total Long-Term Liabilities $10.56M $10.99M $13.89M
YoY Change -17.83% -20.86% -9.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.676M $10.14M $7.723M
Total Long-Term Liabilities $10.56M $10.99M $13.89M
Total Liabilities $20.23M $21.14M $21.61M
YoY Change -14.48% -2.21% -1.36%
SHAREHOLDERS EQUITY
Retained Earnings $24.82M $19.25M $15.91M
YoY Change 55.28% 21.0% 31.82%
Common Stock $6.767M $6.585M
YoY Change -11.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $31.59M $25.84M $22.27M
YoY Change
Total Liabilities & Shareholders Equity $51.82M $46.98M $43.88M
YoY Change 9.5% 7.04% 3.7%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $3.810M $1.313M $462.0K
YoY Change 171.17% 184.2% -76.9%
Depreciation, Depletion And Amortization $270.0K $210.0K $180.0K
YoY Change 50.0% 16.67% 0.0%
Cash From Operating Activities $620.0K $2.338M $213.0K
YoY Change -111.74% 997.65% -105.48%
INVESTING ACTIVITIES
Capital Expenditures $150.0K $135.0K -$198.0K
YoY Change -140.76% -168.18% -64.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$8.000K
YoY Change -100.0% -100.0% -100.28%
Cash From Investing Activities -$160.0K -$135.0K -$206.0K
YoY Change -139.9% -34.47% -108.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$553.0K
YoY Change -86.18%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 370.0K -497.0K -498.0K
YoY Change -61.7% -0.2% 453.33%
NET CHANGE
Cash From Operating Activities 620.0K 2.338M 213.0K
Cash From Investing Activities -160.0K -135.0K -206.0K
Cash From Financing Activities 370.0K -497.0K -498.0K
Net Change In Cash 830.0K 1.706M -491.0K
YoY Change -121.22% -447.45% -70.42%
FREE CASH FLOW
Cash From Operating Activities $620.0K $2.338M $213.0K
Capital Expenditures $150.0K $135.0K -$198.0K
Free Cash Flow $470.0K $2.203M $411.0K
YoY Change -109.57% 436.01% -112.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Central Index Key
EntityCentralIndexKey
0000788920
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2022Q1 us-gaap Interest And Fee Income Loans Other Consumer
InterestAndFeeIncomeLoansOtherConsumer
usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
usd
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
pdex Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock
PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock
usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
usd
pdex Cashless Stock Option Exercise
CashlessStockOptionExercise
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-14942
dei Entity Registrant Name
EntityRegistrantName
PRO-DEX, INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1261240
dei Entity Address Address Line1
EntityAddressAddressLine1
2361 McGaw Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92614
dei City Area Code
CityAreaCode
(949)
dei Local Phone Number
LocalPhoneNumber
769-3200
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
PDEX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3545309 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2088000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
849000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
1149000 usd
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
755000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10565000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15384000 usd
CY2023Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
279000 usd
CY2022Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
710000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
15145000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
12678000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1919000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
790000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
31145000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
31166000 usd
CY2023Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
6273000 usd
CY2022Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
6343000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5162000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4833000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1968000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2248000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
87000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
118000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
764000 usd
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
797000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
1534000 usd
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
1779000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42000 usd
CY2023Q1 us-gaap Assets
Assets
46975000 usd
CY2022Q2 us-gaap Assets
Assets
47326000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3068000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3761000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2425000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2751000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
57000 usd
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1013000 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1480000 usd
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
544000 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
3114000 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
3285000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10144000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11354000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1745000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2054000 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
9247000 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
10250000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10992000 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12304000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
21136000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
23658000 usd
CY2023Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3545309 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3545309 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3596131 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3596131 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
6585000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
7682000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
19254000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15986000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
25839000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
23668000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46975000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47326000 usd
CY2023Q1 us-gaap Revenues
Revenues
13079000 usd
CY2022Q1 us-gaap Revenues
Revenues
9265000 usd
us-gaap Revenues
Revenues
35448000 usd
us-gaap Revenues
Revenues
29426000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
9268000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
6407000 usd
us-gaap Cost Of Revenue
CostOfRevenue
26058000 usd
us-gaap Cost Of Revenue
CostOfRevenue
19737000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
3811000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
2858000 usd
us-gaap Gross Profit
GrossProfit
9390000 usd
us-gaap Gross Profit
GrossProfit
9689000 usd
CY2023Q1 us-gaap Selling Expense
SellingExpense
24000 usd
CY2022Q1 us-gaap Selling Expense
SellingExpense
20000 usd
us-gaap Selling Expense
SellingExpense
146000 usd
us-gaap Selling Expense
SellingExpense
79000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1009000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1145000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2983000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3402000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-14000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-14000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
713000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
658000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2109000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2254000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1746000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1837000 usd
us-gaap Operating Expenses
OperatingExpenses
5238000 usd
us-gaap Operating Expenses
OperatingExpenses
5749000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2065000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1021000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
4152000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3940000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
131000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
112000 usd
us-gaap Interest Expense
InterestExpense
389000 usd
us-gaap Interest Expense
InterestExpense
349000 usd
CY2023Q1 pdex Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investment
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment
-177000 usd
CY2022Q1 pdex Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investment
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment
-275000 usd
pdex Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investment
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment
231000 usd
pdex Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investment
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment
-427000 usd
CY2023Q1 us-gaap Interest And Fee Income Loans Other Consumer
InterestAndFeeIncomeLoansOtherConsumer
11000 usd
us-gaap Interest And Fee Income Loans Other Consumer
InterestAndFeeIncomeLoansOtherConsumer
235000 usd
us-gaap Interest And Fee Income Loans Other Consumer
InterestAndFeeIncomeLoansOtherConsumer
50000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
7000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1768000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
634000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4236000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3214000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
455000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
172000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
968000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
764000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1313000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
462000 usd
us-gaap Net Income Loss
NetIncomeLoss
3268000 usd
us-gaap Net Income Loss
NetIncomeLoss
2450000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3548000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3626000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3580000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3645000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3623000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3749000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3656000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3774000 shares
CY2023Q1 us-gaap Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
3545000 shares
CY2022Q1 us-gaap Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
3618000 shares
us-gaap Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
3545000 shares
us-gaap Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
3618000 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
23668000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1313000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
462000 usd
us-gaap Net Income Loss
NetIncomeLoss
3268000 usd
us-gaap Net Income Loss
NetIncomeLoss
2450000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
25839000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22271000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
25839000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22271000 usd
us-gaap Net Income Loss
NetIncomeLoss
3268000 usd
us-gaap Net Income Loss
NetIncomeLoss
2450000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
594000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
546000 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-8000 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-7000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
584000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
932000 usd
pdex Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investment
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment
231000 usd
pdex Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investment
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment
-427000 usd
pdex Noncash Straightline Lease Amortization
NoncashStraightlineLeaseAmortization
-1000 usd
pdex Noncash Straightline Lease Amortization
NoncashStraightlineLeaseAmortization
10000 usd
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
7000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
61000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
33000 usd
pdex Bad Debt Expense Recovery
BadDebtExpenseRecovery
-2000 usd
pdex Bad Debt Expense Recovery
BadDebtExpenseRecovery
2000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-4817000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-2255000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-431000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
148000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2467000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3429000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1129000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
863000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1047000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
673000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-956000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
746000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
936000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
767000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4835000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4432000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
334000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
822000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1270000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
89000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
32000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-733000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1636000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1547000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1255000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
89000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
60000 usd
pdex Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock
PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock
-223000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3584000 usd
pdex Principal Payments On Notes Payable And Revolving Loan
PrincipalPaymentsOnNotesPayableAndRevolvingLoan
4766000 usd
pdex Principal Payments On Notes Payable And Revolving Loan
PrincipalPaymentsOnNotesPayableAndRevolvingLoan
561000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2863000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1756000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1239000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1040000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
849000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3721000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2088000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4761000 usd
us-gaap Interest Paid Net
InterestPaidNet
384000 usd
us-gaap Interest Paid Net
InterestPaidNet
311000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1107000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1025000 usd
pdex Cashless Stock Option Exercise
CashlessStockOptionExercise
45000 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
57000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_806_eus-gaap--NatureOfOperations_zvH0ZJGNeFy4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 8.1pt 0 10pt">NOTE 2. <span id="xdx_82F_z3iUGLPZaA95">DESCRIPTION OF BUSINESS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We specialize in the design, development and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We have patented adaptive torque-limiting software and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. We also manufacture and sell rotary air motors to a wide range of industries.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In August 2020, we formed a wholly owned subsidiary, PDEX Franklin, LLC (“PDEX Franklin”), to hold title for an approximate 25,000 square foot industrial building in Tustin, California (the “Franklin Property”) that we acquired on November 6, 2020, in order to allow for the continued growth of our business. The condensed consolidated financial statements include the accounts of the Company and PDEX Franklin and all significant inter-company accounts and transactions have been eliminated. This subsidiary has no separate operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>
CY2023Q1 pdex Overtime Revenue Recognition
OvertimeRevenueRecognition
970000 usd
CY2022Q1 pdex Overtime Revenue Recognition
OvertimeRevenueRecognition
549000 usd
pdex Overtime Revenue Recognition
OvertimeRevenueRecognition
2361000 usd
pdex Overtime Revenue Recognition
OvertimeRevenueRecognition
859000 usd
CY2023Q1 pdex Pointintime Revenue Recognition
PointintimeRevenueRecognition
12109000 usd
CY2022Q1 pdex Pointintime Revenue Recognition
PointintimeRevenueRecognition
8716000 usd
pdex Pointintime Revenue Recognition
PointintimeRevenueRecognition
33087000 usd
pdex Pointintime Revenue Recognition
PointintimeRevenueRecognition
28567000 usd
CY2023Q1 us-gaap Revenues
Revenues
13079000 usd
CY2022Q1 us-gaap Revenues
Revenues
9265000 usd
us-gaap Revenues
Revenues
35448000 usd
us-gaap Revenues
Revenues
29426000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
405000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
956000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
877000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
424000 usd
CY2022Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
710000 usd
CY2021Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
193000 usd
CY2023Q1 us-gaap Accretion Expense
AccretionExpense
362000 usd
CY2022Q1 us-gaap Accretion Expense
AccretionExpense
371000 usd
us-gaap Accretion Expense
AccretionExpense
1108000 usd
us-gaap Accretion Expense
AccretionExpense
732000 usd
CY2023Q1 pdex Amounts Reclassified To Cost Of Sales
AmountsReclassifiedToCostOfSales
935000 usd
CY2022Q1 pdex Amounts Reclassified To Cost Of Sales
AmountsReclassifiedToCostOfSales
445000 usd
pdex Amounts Reclassified To Cost Of Sales
AmountsReclassifiedToCostOfSales
1497000 usd
pdex Amounts Reclassified To Cost Of Sales
AmountsReclassifiedToCostOfSales
556000 usd
CY2023Q1 pdex Amounts Allocated To Discounts For Standalone Selling Price
AmountsAllocatedToDiscountsForStandaloneSellingPrice
25000 usd
CY2022Q1 pdex Amounts Allocated To Discounts For Standalone Selling Price
AmountsAllocatedToDiscountsForStandaloneSellingPrice
9000 usd
pdex Amounts Allocated To Discounts For Standalone Selling Price
AmountsAllocatedToDiscountsForStandaloneSellingPrice
42000 usd
pdex Amounts Allocated To Discounts For Standalone Selling Price
AmountsAllocatedToDiscountsForStandaloneSellingPrice
28000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
279000 usd
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
341000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
279000 usd
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
341000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
851000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
584000 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1013000 usd
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
150000 usd
CY2023Q1 us-gaap Proceeds From Customers For Progress Payments
ProceedsFromCustomersForProgressPayments
41000 usd
CY2022Q1 us-gaap Proceeds From Customers For Progress Payments
ProceedsFromCustomersForProgressPayments
861000 usd
us-gaap Proceeds From Customers For Progress Payments
ProceedsFromCustomersForProgressPayments
741000 usd
us-gaap Proceeds From Customers For Progress Payments
ProceedsFromCustomersForProgressPayments
1393000 usd
CY2023Q1 pdex Amounts Reclassified To Revenue
AmountsReclassifiedToRevenue
835000 usd
CY2022Q1 pdex Amounts Reclassified To Revenue
AmountsReclassifiedToRevenue
549000 usd
pdex Amounts Reclassified To Revenue
AmountsReclassifiedToRevenue
1697000 usd
pdex Amounts Reclassified To Revenue
AmountsReclassifiedToRevenue
647000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
57000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
896000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
57000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
896000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
8673000 usd
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
6323000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2991000 usd
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
3463000 usd
CY2023Q1 pdex Inventory Sub Assemblies
InventorySubAssemblies
2058000 usd
CY2022Q2 pdex Inventory Sub Assemblies
InventorySubAssemblies
2118000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1423000 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
774000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
15145000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
12678000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
1149000 usd
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
755000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
1534000 usd
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
1779000 usd
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
2683000 usd
CY2022Q2 us-gaap Marketable Securities
MarketableSecurities
2534000 usd
CY2023Q1 pdex Available For Sale Securities Amortized Costs
AvailableForSaleSecuritiesAmortizedCosts
2714000 usd
CY2022Q2 pdex Available For Sale Securities Amortized Costs
AvailableForSaleSecuritiesAmortizedCosts
2796000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
31000 usd
pdex Marketable Securities Unrealized Loss
MarketableSecuritiesUnrealizedLoss
113000 usd
pdex Marketable Securities Unrealized Gain
MarketableSecuritiesUnrealizedGain
82000 usd
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
262000 usd
CY2022 pdex Marketable Securities Unrealized Loss
MarketableSecuritiesUnrealizedLoss
369000 usd
CY2022 pdex Marketable Securities Unrealized Gain
MarketableSecuritiesUnrealizedGain
107000 usd
CY2023Q1 pdex Investment In Common Stock Affiliated With Company Board Members
InvestmentInCommonStockAffiliatedWithCompanyBoardMembers
1149000 usd
CY2022Q2 pdex Investment In Common Stock Affiliated With Company Board Members
InvestmentInCommonStockAffiliatedWithCompanyBoardMembers
755000 usd
CY2023Q1 us-gaap Land
Land
3684000 usd
CY2022Q2 us-gaap Land
Land
3684000 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings
2815000 usd
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings
2815000 usd
CY2023Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
6499000 usd
CY2022Q2 us-gaap Land And Land Improvements
LandAndLandImprovements
6499000 usd
CY2023Q1 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
226000 usd
CY2022Q2 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
156000 usd
CY2023Q1 pdex Land And Building Net
LandAndBuildingNet
6273000 usd
CY2022Q2 pdex Land And Building Net
LandAndBuildingNet
6343000 usd
CY2020Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6500000 usd
CY2020Q4 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
1300000 usd
CY2020Q4 pdex Bank Financed
BankFinanced
5200000 usd
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P30Y
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
121000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
90000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
87000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
118000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
7000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
27000 usd
CY2021Q1 us-gaap Acquisition Costs
AcquisitionCosts
46000 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
252000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
340000 usd
CY2023Q1 pdex Product Warranty Expenses
ProductWarrantyExpenses
-77000 usd
CY2022Q1 pdex Product Warranty Expenses
ProductWarrantyExpenses
102000 usd
pdex Product Warranty Expenses
ProductWarrantyExpenses
46000 usd
pdex Product Warranty Expenses
ProductWarrantyExpenses
170000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
344000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
255000 usd
CY2023Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
26000 usd
CY2022Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
52000 usd
CY2023Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
103000 usd
CY2022Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
50000 usd
CY2023Q1 pdex Product Warranty Accrual Amortization And Utilization
ProductWarrantyAccrualAmortizationAndUtilization
15000 usd
CY2022Q1 pdex Product Warranty Accrual Amortization And Utilization
ProductWarrantyAccrualAmortizationAndUtilization
29000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
252000 usd
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
328000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
340000 usd
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
221000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
135000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
117000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
89000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
53000 usd
pdex Product Warranty Accrual Amortization And Utilization
ProductWarrantyAccrualAmortizationAndUtilization
134000 usd
pdex Product Warranty Accrual Amortization And Utilization
ProductWarrantyAccrualAmortizationAndUtilization
63000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
252000 usd
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
328000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1313000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
462000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3268000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2450000 usd
CY2023Q1 pdex Weightedaverage Shares Outstanding Basic
WeightedaverageSharesOutstandingBasic
3548000 shares
CY2022Q1 pdex Weightedaverage Shares Outstanding Basic
WeightedaverageSharesOutstandingBasic
3626000 shares
pdex Weightedaverage Shares Outstanding Basic
WeightedaverageSharesOutstandingBasic
3580000 shares
pdex Weightedaverage Shares Outstanding Basic
WeightedaverageSharesOutstandingBasic
3645000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1313000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
462000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3268000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2450000 usd
CY2023Q1 pdex Weightedaverage Shares Outstanding Diluted
WeightedaverageSharesOutstandingDiluted
3548000 shares
CY2022Q1 pdex Weightedaverage Shares Outstanding Diluted
WeightedaverageSharesOutstandingDiluted
3626000 shares
pdex Weightedaverage Shares Outstanding Diluted
WeightedaverageSharesOutstandingDiluted
3580000 shares
pdex Weightedaverage Shares Outstanding Diluted
WeightedaverageSharesOutstandingDiluted
3645000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
75000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
123000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
76000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
129000 shares
CY2023Q1 pdex Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share
WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare
3623000 shares
CY2022Q1 pdex Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share
WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare
3749000 shares
pdex Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share
WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare
3656000 shares
pdex Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share
WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare
3774000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
59000 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
70000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6500 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.82
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
31500 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.81
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.82
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.80
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6500 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.82
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
6500 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.82
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y3M
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
406000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
127000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
519000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
535000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
551000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
567000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
143000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2442000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
291000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2151000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0553 pure
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
139000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
418000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
123000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
366000 usd

Files In Submission

Name View Source Status
pdex-20230331_pre.xml Edgar Link unprocessable
0001553350-23-000285-index-headers.html Edgar Link pending
0001553350-23-000285-index.html Edgar Link pending
0001553350-23-000285.txt Edgar Link pending
0001553350-23-000285-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pdex-20230331.xsd Edgar Link pending
pdex-20230331_lab.xml Edgar Link unprocessable
pdex-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pdex-20230331_def.xml Edgar Link unprocessable
pdex_10q-033123.htm Edgar Link pending
pdex_ex31z1.htm Edgar Link pending
pdex_ex31z2.htm Edgar Link pending
pdex_ex32z1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
pdex_10q-033123_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending